Vanguard Total Stock Market ETF (VTI)
261.45
+4.02 (1.56%)
NYSE · Last Trade: Apr 11th, 2:28 PM EDT
WBD highlighted that Malone will regularly attend Board meetings and provide strategic counsel and support to the Board and management team.
Via Stocktwits · April 11, 2025
Canada’s Competition Bureau is investigating allegations of conduct that can prevent or limit competition in the pharmacy retail market, including “patient steering” and “margin squeezing.”
Via Stocktwits · April 11, 2025
Revenue rose 17% year-over-year to $17.74 billion during the quarter, surpassing a Wall Street estimate of $16.55 billion. Earnings per share stood at $2.6 versus an estimated $2.21.
Via Stocktwits · April 11, 2025
JPMorgan, which holds a ‘Neutral’ rating on the stock, opined that Charles River could see disruption from customers reassessing its preclinical strategies in the near term.
Via Stocktwits · April 11, 2025
PacBio Stock Soars On Plans To Reduce Spending Over NIH Funding Uncertainty, Tariffs: Retail Is Overjoyedstocktwits.com
Via Stocktwits · April 9, 2025
Fink said in a prepared statement in the earnings report that uncertainty and anxiety about the future of markets and the economy are dominating client conversations.
Via Stocktwits · April 11, 2025
Revenue rose 3% year-over-year to $20.15 billion, which failed to meet an analyst estimate of $20.76 billion, per FinChat data. Earnings per share stood at $1.39 versus a Street estimate of $1.22. Net income rose 6% to $4.89 billion.
Via Stocktwits · April 11, 2025
Lucid will take over Nikola's former Coolidge manufacturing facility and the Phoenix facility, which was previously Nikola's headquarters and product development center.
Via Stocktwits · April 11, 2025
Revenue rose 8% year-over-year to $45.31 billion, surpassing a Wall Street estimate of $44.10 billion, per FinChat data. Earnings per share came in at $5.07 versus a Street estimate of $4.65.
Via Stocktwits · April 11, 2025
BNY reported a 6% year-over-year rise in first-quarter revenue to $4.79 billion, which topped a Wall Street estimate of $4.77 billion, per FinChat data. Adjusted earnings per share came in at $1.58 versus a Street expectation of $1.49.
Via Stocktwits · April 11, 2025
Tesla’s China website now allows customers to order only the Model 3 sedan and the Model Y SUV.
Via Stocktwits · April 11, 2025
Stifle has cut price targets "across the board" by an average of 18% across the analyst's sports and lifestyle brands coverage.
Via Stocktwits · April 11, 2025
Woodring suggested that Apple capitalize on the 90-day pause and look to its ODMs in India, namely Hon Hai, Pegatron and Tata, for ramping up production and meeting U.S. iPhone demand.
Via Stocktwits · April 11, 2025
The eliminations followed buyout offers extended by the company to the division's employees in January.
Via Stocktwits · April 11, 2025
The rollout follows a pilot program with Wolt, DoorDash’s international arm, in Helsinki, Finland, where Coco robots have been making deliveries since early this year.
Via Stocktwits · April 10, 2025
The new trade policies, UBS said, are raising the cost of making a vehicle, subsequently raising the cost of a vehicle for consumers and negatively impacting demand.
Via Stocktwits · April 10, 2025
The company said the plan aims to reduce the likelihood of any entity or person gaining control of Keros through open-market accumulation without paying all stockholders an appropriate control premium.
Via Stocktwits · April 10, 2025
Prada said that the transaction will be funded by €1.5 billion of new debt composed of €1.0 billion term loan and €0.5 billion bridge facility.
Via Stocktwits · April 10, 2025
UBS estimates that if left unmitigated, GM's annual cost headwind from tariffs could be $5B.
Via Stocktwits · April 10, 2025
Ives estimates conservatively that 10%-15% of many cloud and AI initiatives in the U.S. he is tracking in the field could be pushed/slowed down during this period of uncertainty.
Via Stocktwits · April 10, 2025
Several Wall Street analysts cut their price targets for Apple’s stock factoring in the negative impact of tariffs on the company’s top- and bottom-line.
Via Stocktwits · April 10, 2025
hares of the company, which is struggling with a declining business and high debt levels, fell over 60% after the report.
Via Stocktwits · April 9, 2025
Morgan Stanley said the company is relatively resilient in a weaker global macro environment.
Via Stocktwits · April 9, 2025
The new price target implies a 19.4% decline from the stock’s closing price of $8.69 on Tuesday.
Via Stocktwits · April 9, 2025
Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.
Via Stocktwits · April 9, 2025